Browsing: health policy

Dr. Vinay Prasad’s resignation from the FDA amid political pressure and controversy highlights ongoing debates over drug approval standards and regulatory transparency in healthcare.

The U.S.–EU trade agreement sparks uncertainty in the pharmaceutical sector, risking $100 billion in EU investments and disrupting global drug supply chains and innovation.